Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union

R3 Continuum Expands Clinical Leadership Team to Accelerate Growth and Market Impact

NextPlat Expects Q1 2026 Gross Margins to Jump to 34+%, Operating Expenses to Decline 8+% From Q4 2025 and Achieve Positive Operating Income in Q3

China's Yangtze River Pharmaceutical Group Expands Global Footprint as Quality Drives Growth

Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025

PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® - Early-Stage Invasive Breast Cancer Assay

Life Time's LT Pro 48 Pickleball Named Official Ball of Major League Pickleball; 2026 Season Kicks off in Dallas May 22

Energenesis Biomedical to Present Clinical Application of ENERGI-F703DFU for Diabetic Foot Ulcers at EWMA 2026

Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biology

INTCO Medical Reports 2025 Results with Resilient Growth, Revenue Reaches Four-Year High as Industry Rebalances

Greywolf Therapeutics and Genomics Launch Strategic Relationship to Develop First‑in‑Class Treatments for Autoimmune Diseases

Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study

CONCEPT MEDICAL STELLT VORLÄUFIGE 3-JAHRES-DATEN ZU SIRONA AUF DEM CHARING CROSS SYMPOSIUM 2026 VOR

U.S. FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options

Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test

Golden State Dermatology Expands Bay Area Presence with Addition of Todd Anhalt, MD in Los Altos

Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA

NEW NATIONAL SURVEY FINDS HOSPITALS SEEN AS STRONG COMMUNITY PARTNERS EARN SIGNIFICANTLY HIGHER TRUST, ADVOCACY AND CONSUMER PREFERENCE

Target Hospitality Announces Launch of Secondary Offering

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

Donor Network West and UCSF Establish Scalable Model to Expand Real-Time Access to Viable Human Organs and Tissue for Research

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL HEALTHCARE CONFERENCE

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

Solventum to Participate in the 2026 Jefferies Healthcare Conference

Nuvation Bio to Present at the Jefferies Global Healthcare Conference

Nobu anuncia la apertura de un restaurante y residencias en Bellevue, Washington

Solu Therapeutics Granted FDA Fast Track Designation for STX-0712 for Treatment of Chronic Myelomonocytic Leukemia

Healthgrades Names Los Angeles Community Hospitals a 2026 Patient Safety Excellence Award™ Recipient

PartsSource Introduces New Asset Uptime Capabilities to Help Health Systems Maximize Clinical Capacity and Asset Performance